↓ Skip to main content

Genetic therapies for cystic fibrosis lung disease

Overview of attention for article published in Current Opinion in Pharmacology, June 2017
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (65th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter
3 tweeters
patent
1 patent

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
131 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Genetic therapies for cystic fibrosis lung disease
Published in
Current Opinion in Pharmacology, June 2017
DOI 10.1016/j.coph.2017.10.006
Pubmed ID
Authors

Stephen L Hart, Patrick T Harrison

Abstract

Gene therapy for cystic fibrosis (CF) has been the subject of intense research over the last twenty-five years or more, using both viral and liposomal delivery methods, but so far without the emergence of a clinical therapy. New approaches to CF gene therapy involving recent improvements to vector systems, both viral and non-viral, as well as new nucleic acid technologies have led to renewed interest in the field. The field of therapeutic gene editing is rapidly developing with the emergence of CRISPR/Cas9 as well as chemically modified mRNA therapeutics. These new types of nucleic acid therapies are also a good fit with delivery by non-viral delivery approaches which has led to a renewed interest in lipid-based and other nanoformulations.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 131 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 131 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 47 36%
Student > Ph. D. Student 14 11%
Student > Master 13 10%
Researcher 8 6%
Student > Doctoral Student 5 4%
Other 7 5%
Unknown 37 28%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 33 25%
Medicine and Dentistry 16 12%
Agricultural and Biological Sciences 14 11%
Pharmacology, Toxicology and Pharmaceutical Science 10 8%
Nursing and Health Professions 8 6%
Other 11 8%
Unknown 39 30%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 December 2021.
All research outputs
#6,063,877
of 20,494,250 outputs
Outputs from Current Opinion in Pharmacology
#484
of 1,381 outputs
Outputs of similar age
#115,395
of 339,040 outputs
Outputs of similar age from Current Opinion in Pharmacology
#16
of 45 outputs
Altmetric has tracked 20,494,250 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 1,381 research outputs from this source. They receive a mean Attention Score of 4.9. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 339,040 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 45 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.